Gazit S - Search Results

1

Dynamics in COVID-19 symptoms during different waves of the pandemic among children infected with SARS-CoV-2 in the ambulatory setting.

Ben-Tov A, Lotan R, Gazit S, Chodick G, Perez G, Mizrahi-Reuveni M, Patalon T. Ben-Tov A, et al. Among authors: gazit s. Eur J Pediatr. 2022 Jul 1. doi: 10.1007/s00431-022-04531-7. Online ahead of print. Eur J Pediatr. 2022. PMID: 35778524

2

Early Oxygen Treatment Measurements Can Predict COVID-19 Mortality: A Preliminary Study.

Levi Y, Yamin D, Brandes T, Shmueli E, Patalon T, Peretz A, Gazit S, Nahir B. Levi Y, et al. Among authors: gazit s. Healthcare (Basel). 2022 Jun 20;10(6):1146. doi: 10.3390/healthcare10061146. Healthcare (Basel). 2022. PMID: 35742198 Free PMC article.

3

Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine.

Patalon T, Saciuk Y, Peretz A, Perez G, Lurie Y, Maor Y, Gazit S. Patalon T, et al. Among authors: gazit s. Nat Commun. 2022 Jun 9;13(1):3203. doi: 10.1038/s41467-022-30884-6. Nat Commun. 2022. PMID: 35680872 Free PMC article.

4

Self-Reported and Physiologic Reactions to Third BNT162b2 mRNA COVID-19 (Booster) Vaccine Dose.

Mofaz M, Yechezkel M, Guan G, Brandeau ML, Patalon T, Gazit S, Yamin D, Shmueli E. Mofaz M, et al. Among authors: gazit s. Emerg Infect Dis. 2022 Jul;28(7):1375-1383. doi: 10.3201/eid2807.212330. Epub 2022 Jun 2. Emerg Infect Dis. 2022. PMID: 35654410 Free PMC article.

5

Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study.

Gazit S, Saciuk Y, Perez G, Peretz A, Pitzer VE, Patalon T. Gazit S, et al. BMJ. 2022 May 24;377:e071113. doi: 10.1136/bmj-2022-071113. BMJ. 2022. PMID: 35609888 Free PMC article.

6

SARS-CoV-2 Naturally Acquired Immunity vs. Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: a Retrospective Cohort Study.

Gazit S, Shlezinger R, Perez G, Lotan R, Peretz A, Ben-Tov A, Herzel E, Alapi H, Cohen D, Muhsen K, Chodick G, Patalon T. Gazit S, et al. Clin Infect Dis. 2022 Apr 5:ciac262. doi: 10.1093/cid/ciac262. Online ahead of print. Clin Infect Dis. 2022. PMID: 35380632 Free PMC article.

7

Waning of SARS-CoV-2 booster viral-load reduction effectiveness.

Levine-Tiefenbrun M, Yelin I, Alapi H, Herzel E, Kuint J, Chodick G, Gazit S, Patalon T, Kishony R. Levine-Tiefenbrun M, et al. Among authors: gazit s. Nat Commun. 2022 Mar 4;13(1):1237. doi: 10.1038/s41467-022-28936-y. Nat Commun. 2022. PMID: 35246560 Free PMC article.

8

The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine : A Retrospective Cohort Study.

Gazit S, Shlezinger R, Perez G, Lotan R, Peretz A, Ben-Tov A, Herzel E, Alapi H, Cohen D, Muhsen K, Chodick G, Patalon T. Gazit S, et al. Ann Intern Med. 2022 May;175(5):674-681. doi: 10.7326/M21-4130. Epub 2022 Feb 15. Ann Intern Med. 2022. PMID: 35157493 Free PMC article. Clinical Trial.

9

Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel.

Prunas O, Warren JL, Crawford FW, Gazit S, Patalon T, Weinberger DM, Pitzer VE. Prunas O, et al. Among authors: gazit s. Science. 2022 Mar 11;375(6585):1151-1154. doi: 10.1126/science.abl4292. Epub 2022 Jan 27. Science. 2022. PMID: 35084937

10

Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents.

Prunas O, Weinberger DM, Pitzer VE, Gazit S, Patalon T. Prunas O, et al. Among authors: gazit s. medRxiv. 2022 Jan 5:2022.01.04.22268776. doi: 10.1101/2022.01.04.22268776. Preprint. medRxiv. 2022. PMID: 35018389 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results